Search clinical trials for: aspirin plus dipyridamole

Total 6059 results

National Institute of Diabetes and Digestive and...
Boston University; Washington University School of Medicine; University of Alabama... and other collaborators

Completed

Aggrenox Prevention of Access Stenosis (GRAFT)

Kidney Failure

United States
University of Roma La Sapienza
Civic Hospital, Italy

Completed

Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization (ICAR)

Stroke | Cardiovascular Disease | Atherosclerosis | Carotid Stenosis

Italy
Boehringer Ingelheim

Completed

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Coronary Arteriosclerosis

Ireland
University of Pennsylvania
Boehringer Ingelheim

Terminated

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease

United States
Boehringer Ingelheim

Completed

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Cerebrovascular Accident

Germany
UMC Utrecht

Completed

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Arteriosclerosis | Brain Ischemia | Transient Ischemic Attack

Netherlands
Oklahoma Medical Research Foundation

Terminated

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) (DARE)

Systemic Lupus Erythematosus

United States
Boehringer Ingelheim

Completed

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

Healthy
Zalicus

Completed

Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis (MARS-1)

Rheumatoid Arthritis

United States, Poland, Argentina, Romania, Serbia, Canada, Estonia, Russian Federation, Lithuania, South Africa, Hungary, Mexico
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Recurrent Carotid Stenosis

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Carotid Stenosis
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Platelet Drug Trial in Coronary Disease Progression

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Boehringer Ingelheim

Completed

Tolerability of Asasantin in Healthy Female and Male Subjects

Healthy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina Pectoris
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

Healthy
Zalicus

Terminated

CRx-102 Osteoarthritis Multicenter Evaluation Trial (COMET-1)

Knee Osteoarthritis

United States, Canada
Rutgers, The State University of New Jersey
Boehringer Ingelheim

Completed

Aggrenox To Treat Acute Covid-19 (ATTAC-19)

Covid19

United States
UConn Health
United States Department of Defense

Terminated

Persantine: Variation in Response Trial

Coronary Artery Disease

United States
Boehringer Ingelheim

Completed

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

Healthy
University of Oxford

Completed

A Short SPIRIT Checklist for Peer Reviewers to Improve the Reporting Quality in Published Articles (SPIRIT-PR) (SPIRIT-PR)

Adequate Reporting in Published Study Protocols of Randomized Controlled Trials

United Kingdom
St George's, University of London
The Stroke Association, United Kingdom

Completed

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection (CADISS)

Stroke | Cervical Artery Dissection | Vertebral Artery Dissection | Carotid Artery Dissection

United Kingdom
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Radboud University Medical Center

Completed

Persantin Preceding Elective PCI (P3)

Atherosclerosis | Coronary Heart Disease | Percutaneous Transluminal Coronary Angioplasty

Netherlands
Boehringer Ingelheim

Completed

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

Cerebrovascular Accident

Taiwan
IRCCS San Raffaele
Servier

Completed

Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk

Hypertension,Essential

Italy
UConn Health

Terminated

Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD)

COVID-19 Pneumonia | Vascular Complications

United States
Radboud University Medical Center

Completed

Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

Atherosclerosis | Ischemia-Reperfusion Injury

Netherlands
University of Athens

Completed

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI (PTOLEMAIOS)

Aortic Valve Stenosis

Greece
University of Michigan

Completed

Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 (DICER)

Covid-19 | COVID | Corona Virus Infection | SARS-CoV-2 Infection

United States
Boehringer Ingelheim

Completed

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Healthy
Samsung Medical Center
Seoul St. Mary's Hospital; Chonnam National University Hospital; Gachon University... and other collaborators

Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (ATTEMPT)

Coronary Artery Disease

Korea, Republic of
Children's Hospital Medical Center, Cincinnati

Withdrawn

Dipyridamole/Magnesium To Improve Sickle Cell Hydration

Anemia, Sickle Cell

United States
Sharon Riddler
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Dipyridamole for Immune Activation in HIV

HIV Infection

United States
University of Nottingham

Terminated

Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke (TARDIS)

Stroke

United Kingdom
Radboud University Medical Center

Completed

Metformin-Dipyridamole Interaction Trial (MetDipy)

Diabetes

Netherlands
Boehringer Ingelheim

Terminated

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects

Healthy
Groupe Hospitalier Paris Saint Joseph

Completed

Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population

Proton Pump Inhibitor

France
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Multiple Myeloma and Plasma Cell Neoplasm

United States
Boehringer Ingelheim

Completed

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Cerebrovascular Accident

Japan
Boehringer Ingelheim

Completed

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Healthy
Second Affiliated Hospital, School of Medicine,...

Recruiting

Antiplatelet Therapy for AIS Patients With Thrombocytopenia (PERSIST)

Thrombocytopenia | Acute Ischemic Stroke

China
Hillel Yaffe Medical Center

Unknown

"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Coronary Angiography

Israel
Boehringer Ingelheim

Completed

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

Healthy

United States
Ottawa Hospital Research Institute
The Ottawa Hospital

Completed

Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia (RIVAL-PAD)

Critical Limb Ischemia

Canada
Yonsei University

Terminated

Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease

Coronary Artery Disease | Atrial Fibrillation

Korea, Republic of
Universidade Estadual Paulista Júlio de Mesquita...
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Effects of Omega-3 Plus Low-dose Aspirin as Adjunct to Periodontal Debridement for Chronic Periodontitis in Diabetics

Diabetes Mellitus | Chronic Periodontitis

Brazil
Chulalongkorn University

Active, not recruiting

Antiplatelet Therapy in Chronic Urticaria

Chronic Urticaria

Thailand

3

Subscribe